San Diego, CA, United States of America

Vadim Cherezov

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Vadim Cherezov: Pioneering Innovations in Membrane Protein Research

Introduction

Vadim Cherezov is a distinguished inventor based in San Diego, California, known for his significant contributions to the field of membrane protein research. With a total of two patents to his name, Cherezov has focused on advancing the understanding and therapeutic applications of G-protein coupled receptors.

Latest Patents

Cherezov's latest patents include a groundbreaking invention that outlines the structure of human Adenosine receptor protein bound to an antagonist. This invention provides valuable methods for utilizing binding sites and other characteristics of this receptor to develop new therapeutics. Additionally, he has developed methods and compositions for obtaining high-resolution crystals of membrane proteins, which are crucial for detailed structural analysis and subsequent drug design.

Career Highlights

Vadim Cherezov works at The Scripps Research Institute, an esteemed institution renowned for its advanced research in biomedical sciences. His contributions to the field are fundamentally changing how researchers understand receptor biology and membrane protein crystallization.

Collaborations

Cherezov collaborates with prominent colleagues in his field, including Raymond C. Stevens and Michael Allen Hanson. These collaborations enhance the innovative capacity of their research endeavors, enabling impactful findings and advancements in therapeutic technologies.

Conclusion

Vadim Cherezov’s work exemplifies the spirit of innovation in scientific research. Through his patents and collaborations, he is paving the way for new medical therapies and a deeper understanding of membrane proteins, positioning himself as a key figure in biomedical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…